“IN SILICO STUDY OF VANILLIN SCHIFF BASES AS PROTO ONCOGENE TYROSINE KINASE INHIBITORS OF CHRONIC MYELOID LEUKEMIA”. Frontier in Medical and Health Research, vol. 3, no. 10, Dec. 2025, pp. 570-7, https://fmhr.net/index.php/fmhr/article/view/1765.